ADDPI 2019_157 INADA vs Vaibhav Ganpatrao Markantewar

In June 2019 the India National Anti-Doping Agency (INADA) has reported an anti-doping rule violation against the bodybuilder Vaibhav Ganpatrao Markantewar after his sample tested positive for the prohibited substances Clenbuterol, Furosemide, Growth Hormone Releasing Peptide (GHRP), Mesterolone and Stanozolol.

After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI). The Athlete denied the intentional use and explained that he had used these substances on advise of his personal coach.

The Panel finds that the test result showed the presence of the prohibited substances in the Athlete’s sample and accordingly that he committed an anti-doping rule violation.
The Panel concludes that the Athlete failed to establish that the violation was not intentional and decides therefore on 16 December 2019 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 7 June 2019.

Original document

Parameters

Legal Source
National Decisions
Date
16 December 2019
Arbitrator
Chandran, P.S.M.
Dhanda, Vineet
Singh, Jagbir
Original Source
India National Anti-Doping Agency (INADA)
Country
India
Language
English
ADRV
Adverse Analytical Finding / presence
Sport/IFs
Bodybuilding & Fitness (IFBB) - International Federation of Bodybuilding & Fitness
Other organisations
Anti-Doping Disciplinary Panel of India (ADDPI)
India National Anti-Doping Agency (INADA)
Laboratories
New Delhi, India: National Dope Testing Laboratory
Doping classes
S1. Anabolic Agents
S2. Peptide Hormones, Growth Factors
S5. Diuretics and Other Masking Agents
Substances
Clenbuterol
Furosemide
GHRP-2 (pralmorelin)
Growth Hormone Releasing Peptide (GHRP)
Mesterolone
Stanozolol
Document type
Pdf file
Date generated
29 January 2020
Date of last modification
17 February 2020
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin